Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma

Melanoma Res. 2018 Aug;28(4):368-369. doi: 10.1097/CMR.0000000000000460.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Ipilimumab / adverse effects*
  • Melanoma / complications*
  • Melanoma / pathology
  • Nivolumab / adverse effects*
  • Skin Neoplasms / complications*
  • Skin Neoplasms / pathology
  • Thyroiditis / chemically induced*
  • Thyroiditis / pathology

Substances

  • Ipilimumab
  • Nivolumab